Breaking News

  • 5 hours ago

  • Pharma Now Editorial Team

Lupin Gains FDA Approval for Generic Sutab Tablets with 180-Day Exclusivity
Breaking News

More News

Lupin Gains FDA Approval for Generic Colonoscopy Prep Drug with 180-Day First-to-File Exclusivity

Lupin Gains FDA Approval for Generic Colonoscopy Prep Drug with 180-Da...

Pharma Now Editorial Team

AstraZeneca Gains FDA Approval for Imfinzi Combination Regimen in Bladder Cancer

AstraZeneca Gains FDA Approval for Imfinzi Combination Regimen in Blad...

Pharma Now Editorial Team

Merck Gains FDA Breakthrough Therapy Designation for Calderasib in KRAS G12C Lung Cancer

Merck Gains FDA Breakthrough Therapy Designation for Calderasib in KRA...

Pharma Now Editorial Team

AstraZeneca Reports Mixed Phase III Results for Anselamimab in Cardiac AL Amyloidosis Trial

AstraZeneca Reports Mixed Phase III Results for Anselamimab in Cardiac...

Pharma Now Editorial Team

Ad
Advertisement

Interviews & Opinions

Article

“If You Want to Be a King, First Behave Like One” Naresh Kumar Gaur on Leadership & Ownership

Naresh Kumar Gaur says pharma titles follow behaviour, not the other way around. Why most professionals are waiting for a crown they have to earn firs...

FT - Mr. Naresh Kumar Gaur

Read More

Article
From ‘Why Reject?’ to ‘How Release?’: Deepak Kasbi on the Cultural Shift in Pharma Quality

FT - Mr. Deepak Kasbi

Article
Five Pillars Of Leadership That Built A Pharma Veteran: Shyam Khante’s 45-Year Pharma Journey

FT - Mr. Shyam Khante

Article
“Quality is Driven by Science” – Leadership Lessons from Zydus President Vikram Shukla

FT - Mr. Vikram Shukla

Ad
Advertisement
Ad